Position in MGTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$122,941,000
+$62,321,000 QoQ
Shares Held
9,100,000
+30.0% QoQ
Ownership
9.47%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#3
of 157 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rubric Capital Management LP holds $1,431,610,576 across 20 Biotechnology names. MGTX ranks #5 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
8,271,577 | $216,880,748 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
6,000,000 | $212,340,000 | |
| 3 | ZYME |
Zymeworks Inc.
|
7,000,000 | $182,980,000 | |
| 4 | NRIX |
Nurix Therapeutics, Inc.
|
7,227,778 | $175,345,894 | |
| 5 | MGTX |
MeiraGTx Holdings plc
This page
|
9,100,000 | $122,941,000 | |
| 6 | ARDX |
Ardelyx, Inc.
|
16,202,700 | $82,633,770 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
9,339,414 | $78,170,895 | |
| 8 | MNKD |
Mannkind Corp
|
18,000,000 | $76,680,000 |
All Filings in MGTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $122,941,000 | 9,100,000 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $122,941,000 | 9,100,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $60,620,000 | 7,000,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $49,093,881 | 6,175,331 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $30,668,691 | 3,726,451 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,296,460 | 3,726,451 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,043,456 | 1,776,321 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||